252 related articles for article (PubMed ID: 28415621)
1. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.
Qiu GZ; Mao XY; Ma Y; Gao XC; Wang Z; Jin MZ; Sun W; Zou YX; Lin J; Fu HL; Jin WL
Cancer Sci; 2018 Jul; 109(7):2199-2210. PubMed ID: 29788550
[TBL] [Abstract][Full Text] [Related]
3. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
[TBL] [Abstract][Full Text] [Related]
4. Is co-expression of USP22 and HSP90 more effective in predicting prognosis of gastric cancer?
Zheng H; Yu J; Li W; Yang D; Gao C; Zhang Q; Xu L
Pathol Res Pract; 2019 Apr; 215(4):653-659. PubMed ID: 30598339
[TBL] [Abstract][Full Text] [Related]
5. Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.
Wang XF; Zhang XW; Hua RX; Du YQ; Huang MZ; Liu Y; Cheng YF; Guo WJ
Oncotarget; 2016 Sep; 7(39):63352-63361. PubMed ID: 27542229
[TBL] [Abstract][Full Text] [Related]
6. Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomes.
Yang F; Zheng Z; Xue X; Zheng L; Qin J; Li H; Zhou Y; Fang G
Future Oncol; 2019 Jan; 15(3):281-295. PubMed ID: 30543303
[TBL] [Abstract][Full Text] [Related]
7. Ring finger 220 promotes the stemness and progression of colon cancer cells via Ubiquitin specific peptidase 22-BMI1 axis.
Yan J; Tan M; Yu L; Jin X; Li Y
Bioengineered; 2021 Dec; 12(2):12060-12069. PubMed ID: 34753387
[TBL] [Abstract][Full Text] [Related]
8. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
9. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma.
Yang DD; Cui BB; Sun LY; Zheng HQ; Huang Q; Tong JX; Zhang QF
Cell Biochem Biophys; 2011 Dec; 61(3):703-10. PubMed ID: 21735131
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific peptidase 22 overexpression may promote cancer progression and poor prognosis in human gastric carcinoma.
He Y; Jin YJ; Zhang YH; Meng HX; Zhao BS; Jiang Y; Zhu JW; Liang GY; Kong D; Jin XM
Transl Res; 2015 Mar; 165(3):407-16. PubMed ID: 25445209
[TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
14. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
[TBL] [Abstract][Full Text] [Related]
16. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
[TBL] [Abstract][Full Text] [Related]
17. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth.
Xu H; Liu YL; Yang YM; Dong XS
Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
19. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
[TBL] [Abstract][Full Text] [Related]
20. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
